The results support that circadian misalignment, rather than meal-to-sleep interval, underlies the adverse glucose effects.
Obesity and Health Disparities
Advertisement
Dr. Cory Rice talks about helping patients after they've stopped GLP-1 treatment but still have cardiometabolic challenges.
Between 1990 and 2022, obesity rates quadrupled among girls (from 1.7% to 6.9%) and among boys (from 2.1% to 9.3%) globally.
Dr. Cory Rice discusses alternatives for patients who stop GLP-1s but still need help with disease reversal.
This work represents an important step forward in understanding the complex relationship between socioeconomic status
At the one-year mark, 46% of participants in the intervention group achieved diabetes remission.
Importance of proactive dietary strategies and weight management in midlife to maintain brain health into older age.
Unlike branded medications, compounded products are not required to strictly adhere to FDA's Current Good Manufacturing
High fructose intake and altered sugar metabolism in the brain might contribute to neuroinflammation, amyloid beta production
The commission urges health authorities to recognize obesity as a chronic, potentially life-threatening condition
Studies show that obesity is a risk factor for both Barrett's esophagus and esophageal cancer.
Consumers bought products containing 27% less sugar, 37% less sodium, and 16% less saturated fat after a similar labeling.
Drs. Julie Schulz and Michael Dovidio Discuss Using Lab Values for GLP-1 Drug Coverage.
the potential to narrow the gap in sleep apnea outcomes that exists between well-resourced communities and those that have lo
Drs. Julia Schulz and Michael Dovidio discuss lab values to determine GLP-1 drug coverage and improve prescription access.
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.